Skip to main content
Caplight Logo









DM Capital

DM Capital

Shenzhendmcapital.cn

Overview

DM Capital is a venture capital and private equity firm that focuses on the healthcare industry, including biopharmaceuticals, medical equipment, medical services, and bio-artificial organs.

Year Founded

2001

Portfolio Companies

2

Investments

DM Capital investments
CompanyDateStageLead
Asia Regenerative MedicineOct 2025Series ACo-investor
Rege Nephro Co., Ltd.Jan 2022Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is DM Capital based?

DM Capital is headquartered in Shenzhen, China.

When was DM Capital founded?

DM Capital was founded in 2001.

How many portfolio companies does DM Capital have?

DM Capital has 2 portfolio companies in Caplight's dataset.

What are some companies in DM Capital's portfolio?

Portfolio companies visible on Caplight include Asia Regenerative Medicine, Rege Nephro Co., Ltd..

What was DM Capital's most recent investment shown here?

DM Capital's most recent investment in this portfolio sample was in Asia Regenerative Medicine in 2025.

What sectors does DM Capital focus on?

DM Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.

What company stages does DM Capital focus on?

DM Capital typically invests at the Early stage.

Firmographic Details

HeadquartersShenzhen
Year Founded2001

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?